CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer

Adjuvant chemotherapy has reduced the risk of tumor recurrence and improved survival in patients with resected colorectal cancer. Potential utility of circulating tumor DNA (ctDNA) prior to and post surgery has been reported across various solid tumors. We initiated a new type of adaptive platform t...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Hiroya, Nakamura, Yoshiaki, Kotani, Daisuke, Yukami, Hiroki, Mishima, Saori, Sawada, Kentaro, Shirasu, Hiromichi, Ebi, Hiromichi, Yamanaka, Takeharu, Aleshin, Alexey, Billings, Paul R., Rabinowitz, Matthew, Oki, Eiji, Takemasa, Ichiro, Kato, Takeshi, Mori, Masaki, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253296/
https://www.ncbi.nlm.nih.gov/pubmed/33931919
http://dx.doi.org/10.1111/cas.14926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253296/
https://www.ncbi.nlm.nih.gov/pubmed/33931919
http://dx.doi.org/10.1111/cas.14926

Ejemplares similares